EU: European Union and Commission launch EU4Health funding program to boost healthcare digitalization and make devices more accessible

2023-03-31T13:23:04+00:00March 30th, 2021|Categories: Europe, Innovation|Tags: , , , |

As COVID-19 keeps surging throughout many of the European countries, the EU and EU Commission launched EU4Health, the €5.1 billion funding program targeting EU countries, health organisations and NGOs. Aim of the program is to strengthen the resilience of post [...]

Switzerland: New requirements and changes to authorization practice as of May 2021

2024-02-29T14:31:01+00:00March 24th, 2021|Categories: Clinical Trial, Europe, MDR, Switzerland|Tags: , , , |

Swissmedic has recently announced new regulations and requirements for the authorization of clinical trials in Switzerland. Meditrial and its team based in the Zug office manage several studies in Switzerland and has direct connections with Investigators, hospitals and local [...]

US: FDA provides examples on real world evidence to support marketing applications for medical devices

2024-02-29T16:54:30+00:00March 19th, 2021|Categories: Clinical Trial, USA|Tags: , , , , |

The FDA issued a document reporting examples of real world evidence (RWE) application to support marketing applications for medical devices. The document includes examples of RWE in several submission types: premarket notification 510(k) , De Novo, humanitarian device exemption [...]

EU: EUDAMED UDI/device registration and Certificates and Notified Bodies modules available by September 2021.

2023-04-21T09:20:12+00:00March 5th, 2021|Categories: Compliance, Europe|Tags: , , |

The European Commission announced the activation of the modules on UDI/device registration (second module) and on Certificates and Notified Bodies (third module) by September 2021. The first module on Actor registration is available since December 2020. EUDAMED will act as [...]

EU: MDCG issues guidance on harmonised administrative practices and alternative technical solutions until EUDAMED is fully functional

2023-03-31T13:15:38+00:00March 1st, 2021|Categories: Europe, Regulatory|Tags: , , |

The MDCG issued a new guidance "to Member States and other relevant parties on the application of certain MDR provisions during the absence of EUDAMED. To that end, this guidance intends to describe harmonised administrative practices and alternative technical solutions [...]

EU: The European Commission issues a guidance on management of legacy devices in Eudamed

2023-03-31T13:14:00+00:00February 15th, 2021|Categories: Compliance, Europe, MDR|Tags: , , , |

The European Commission issued a new guidance explaining how legacy devices and in vitro diagnostics (IVDs) will be managed in its Eudamed database, expected to be fully rolled out by May 2022. "Legacy Devices are defined as Medical Devices, Active [...]

EU: EMA expands the use of remote source data verification in clinical trials

2023-03-31T13:12:41+00:00February 9th, 2021|Categories: Clinical Trial, Covid-19, Europe|Tags: , , , , , |

The European Commission and European Medicines Agency’s updated the guidance on managing clinical trials conducted during the COVID-19 pandemic by expanding the use and scope of remote source data verification (rSDV) in clinical trials. While previous versions of the guidance [...]

UK: MHRA updates guidance on virtual manufacturing of medical devices

2024-02-29T16:27:55+00:00February 4th, 2021|Categories: UK|Tags: , , , , |

The UK MHRA has updated a guidance on virtual manufacturing of medical devices. "A virtual manufacturer is an organisation that fully sources its own named product from another company [...] which has designed and manufactured an identical UKCA/CE/CE UKNI [...]

US: CDRH plans full launch of ASCA pilot program in 2021

2023-04-21T10:48:30+00:00January 29th, 2021|Categories: Regulatory, USA|Tags: , , , , |

The US Food and Drug Administration (FDA)’s Center for Devices and Radiological Health (CDRH) annouced the full launch of a pilot conformity assessment program in 2021. Contact Meditrial to know about our strategic assessments of regulatory requirements to address business [...]

Go to Top